A Clinical AI Deployment and Model Drift Auditor Owns the Schedule Nobody Owns

Whose Calendar Does a Drifting Clinical Model Live On?

A sepsis alert that fired well for eighteen months starts firing late on night shift, and nobody can say when it started. The vendor says the model has not changed. The inputs have: an EHR upgrade, a merged rural campus, a different case mix. That degradation is a surveillance event with a clock on it, and right now it sits on nobody's calendar.

That is the seat. A 2026 MedTech roles report names "Clinical AI Deployment Engineers and AI Safety Auditors" who put models into hospital workflows and then "monitor real-world performance", managing "model drift inside a regulated post-market surveillance framework" and validating against clinical evidence ¹. Read the second half of that sentence carefully. The novel work is not the deployment. It is the standing obligation that begins the day the deployment ends.

The duty is what pulls the role out of the MLOps team. An engineer who owns a model's uptime is measured on it working. An auditor is measured on catching the week it stopped working for one group of patients while the aggregate number held. Those two incentives cannot live in the same person, and a health system that merges them will discover drift the way it discovers most quality problems, which is from a clinician who finally wrote it up.

What the job produces is small and specific: a register of every live model, a written performance definition per model per site, a recheck cadence, a threshold that triggers a finding, and a file of findings with what was done about each. Note that this is close cousin work to an AI market surveillance officer on the manufacturer side, and the two seats read each other's output. Obligations here differ by jurisdiction, by whether an organization is a manufacturer or a user of a cleared device, and by what the device's own labeling commits to, so scope the mandate with counsel before writing the description.

What Should This Auditor Ask You Before They Ask for a Dashboard?

Go back to the sepsis alert. A dashboard would have shown the aggregate holding steady, which is why the candidate you want starts somewhere else, with a question they should ask you unprompted: what counts as acceptable performance for this model, in this hospital, for which subgroup, and who signed that definition. Anyone who reaches for tooling before that answer has never had to defend a finding.

Five things are worth listening for in an hour, and in practice they run together. A candidate who separates data drift from outcome drift will tell you that input distributions moving is a warning while patients being harmed differently is a finding, which is the difference between a queue that gets read and one that gets ignored by month four. The same person asks what the ground truth is and when it arrives, because most clinical labels land weeks or months after the prediction, and that lag sets the honest recheck cadence and everything downstream of it. They ask about subgroups by name, and they name the strata before seeing any data, because aggregate performance holds while a model quietly degrades for the night shift, for one campus, for patients on a particular payer pathway. That is the exact shape of the sepsis alert, and the reason nobody caught it for months.

The last two are about the person rather than the method. Ask about a deployment they slowed or pulled, what it cost clinically and commercially, and what they conceded, because no friction in the history means no authority in the seat. Then ask for a redacted write-up and read it: if the medical director cannot get through it in ninety seconds, it will not change practice, and a finding written for the committee changes nothing.

One anti-tell. A candidate who offers to detect whether a vendor's documentation or a colleague's report was written by a model is selling a capability that does not work, and it has nothing to do with this mandate. The job is checking whether a deployed system still performs, in the open, with named humans accountable for each check.

Which Backgrounds Produce This Auditor, and How Did They Get Good With AI?

The obvious feeder is a clinical data scientist who has shipped a model into an EHR. The better and less obvious ones come from disciplines that already re-examine a system after it is in the field: medical device regulatory affairs, hospital quality and patient safety, clinical laboratory science, and pharmacovigilance. Those people arrive knowing what a finding looks like when an external reviewer opens the file.

Laboratory scientists transfer unusually well and get overlooked. Running a clinical lab is continuous quality control against known material, with drift detection, out-of-control rules, corrective action and documentation as ordinary daily practice. Swap the analyzer for a model and most of the discipline survives intact. Pharmacovigilance brings the second habit, which is treating a signal as something to be investigated on a clock rather than argued about. Device regulatory affairs brings the third, which is knowing that a change to the system is an event requiring re-assessment rather than a routine release.

How the strong ones got good with AI is worth asking directly, and the useful answers are unglamorous. Someone who has used an assistant to draft a monitoring plan and then found the two subgroup definitions it invented. Someone who asks a model to summarize a vendor's validation study and then reads the study to check the summary. Someone who keeps the vendor's own performance claims in a file so marketing language can be checked against the manufacturer's disclosure. That habit of interrogating confident text is the job in miniature, because most of the work is deciding which sentence in a plausible report needs a source.

Candidates who have never used these tools misjudge which parts are easy. Candidates who trust the output fail more expensively, since a fabricated statistic in a surveillance file is worse than a gap. Pair this seat with a site AI engineer who owns the integration work, and keep the reporting lines apart.

Recruit Where Clinical Performance Is Already Rechecked on a Schedule

Go where the recheck habit already exists. Hospital quality and patient safety departments, clinical laboratory quality programs, device regulatory affairs and post-market surveillance teams at manufacturers, clinical informatics groups, and the AI governance committees that many health systems stood up over the past two years all concentrate people who have defended a number to somebody outside their own team.

The title is not settled, so search on the duty. Adjacent postings show up as clinical AI safety auditor, AI deployment engineer with a surveillance mandate, clinical AI governance lead, algorithm stewardship analyst, and model risk roles inside payer organizations. Medical device manufacturers are visibly hiring the deployment-plus-monitoring pairing described above ¹, which means a health system competes with vendors for the same candidates and should say plainly what the hospital-side version offers that the vendor side does not, which is proximity to the patients the model actually touches.

Screen on artifacts rather than credentials. Ask every candidate for something an outside party relied on: a monitoring plan, a validation report, a corrective action write-up, a signal investigation. Read it before the conversation. This is a writing and evidence job, and one real document beats a certificate. If the eventual scope includes conformity work for a manufacturer rather than a user, the neighboring seat is a notified body AI conformity assessor, and that is a different hire.

How Do You Close This Auditor, and Does the Work Sit On-Site?

Close on authority first. Everyone worth hiring has watched an oversight seat get talked out of a finding, and they know that catching the sepsis alert firing late is worth nothing if the person who caught it can only recommend. Name the reporting line, what this person can pause without asking, and how an override gets recorded. Say it in the offer letter. A mandate that exists only in the interview does not survive the first inconvenient result.

Pay is the second conversation and honesty helps, because the category is still forming and no established wage series covers this exact title as of September 2026. Rather than quote a number nobody can source, decide which band you are hiring against and present it as the proxy it is. In practice this seat prices against senior medical device regulatory affairs and clinical quality bands, occasionally against clinical data science bands where the scope includes hands-on revalidation. Expect upward pressure from the general AI skills premium: one vendor analysis, PwC's 2026 barometer, put the average premium at about 62 percent for roles requiring AI skills across roughly one billion job ads ². That is an occupation-wide average rather than a rate for this title, so treat it as a reason to budget above your existing quality bands and nothing more.

On location, the analysis, plan writing and finding documentation travel fine, and much of the recheck work is remote by nature. Three parts are not. Patient-level data usually stays inside a controlled environment, which frequently means on-premise access or a locked-down virtual desktop with real onboarding friction. Investigating a signal means sitting with the clinicians who saw it, because the explanation is often a workflow change nobody logged. And the first ninety days are inventory work, finding what is actually running across departments, which goes badly over video with people who have not met you. Remote with scheduled on-site weeks, plus a named data residency arrangement, is the shape to write down rather than negotiate later.

One last thing to decide before posting. If nobody has yet written the performance definitions this person will audit against, you are hiring earlier in the pipeline than the title suggests, and the first two quarters are authoring work rather than auditing. Budget for that instead of being surprised by it.

Read the evidence >